Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB25FSYYB
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,166
Award facts
- Contract value 100% obligated
- $4,165.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $4,165.86 by the Defense Logistics Agency (DLA) on July 14, 2025, for the supply of Nexplanon 68 mg implants. The contract carries a firm fixed-price structure with an ultimate completion date of August 4, 2025, and is not designated as a set-aside award. This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026, which authorizes the agency to procure a comprehensive range of pharmaceutical products and medical supplies supporting Department of Defense healthcare facilities worldwide.
As a key supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group has established a robust portfolio of contract awards with the DLA covering an extensive array of medical products, including prescription medications, biologics, and medical consumables distributed to military healthcare facilities. Nexplanon implants, a contraceptive device, represent one of many specialized pharmaceutical products the company supplies to support the medical needs of military health systems. The company's consistent performance in federal procurement and its woman-owned small business status have enabled it to compete effectively and secure multiple delivery orders through the DLA's centralized pharmaceutical distribution framework.
Quick answers
Who was awarded contract SPE2DB25FSYYB?
SPE2DB25FSYYB was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 14, 2025.
How much is contract SPE2DB25FSYYB worth?
The government has obligated $4,166 on SPE2DB25FSYYB.
Is contract SPE2DB25FSYYB an order under another contract?
Yes. SPE2DB25FSYYB is a delivery order under SPE2DB25D9349, an indefinite delivery contract.
Was contract SPE2DB25FSYYB competed?
The extent of competition for SPE2DB25FSYYB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award